Metal Partially Covered Biliary Stent - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Metal Partially Covered Biliary Stent by Application (Hospital, Medical Center), by Types (Absorbable, Non Absorbable), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $210 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $210 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Metal Partially Covered Biliary Stent Market Size | CAGR 7.2 Forecast 2033

Metal Partially Covered Biliary Stent - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $210 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $210 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Metal Partially Covered Biliary Stent Market Overview

Metal partially covered biliary stents are self‑expanding devices designed to maintain bile duct patency while minimizing tissue ingrowth, primarily used in the management of malignant biliary obstruction. The Metal Partially Covered Biliary Stent market size was estimated at USD 310 million in 2025, and the market forecast projects growth to approximately USD 460 million by 2033, delivering a CAGR of about 5.2% over the 2026‑2033 horizon. This growth outlook is driven by an aging global population, rising incidence of pancreatic and cholangiocarcinoma, and a shift toward minimally invasive endoscopic procedures. Enhanced reimbursement frameworks and ongoing innovations in nitinol alloy technology further underpin the industry expansion.

Loading chart…

Key forces shaping the market include rapid technological shifts—notably drug‑eluting partially covered designs that extend stent patency—and evolving regulatory landscapes that streamline approvals for next‑generation devices. Competitive intensity is escalating as major med‑tech firms expand their portfolios, while supply‑chain resilience for high‑grade nitinol alloys remains pivotal. Geographically, North America retains the largest market share, driven by advanced healthcare infrastructure, whereas the Asia‑Pacific region is the fastest‑growing, propelled by increasing cancer prevalence and expanding endoscopic capabilities across emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	210.00 million
Revenue forecast in 2033	366.25 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Taewoong Medical; Merit Medical; Cook Medical; PNN Medical; Teleflex; C.R. Bard
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising incidence of malignant biliary obstruction driven by aging demographics and expanding prevalence of pancreatic and cholangiocarcinoma is prompting hospitals to adopt Metal Partially Covered Biliary Stent market solutions, thereby expanding the Metal Partially Covered Biliary Stent market size.

Advances in nitinol alloy engineering and anti‑migration coating technologies are delivering longer patency and reduced complication rates, which are being reflected in reimbursement policies and encouraging payers to favor partially covered metal stents in the growth forecast.

Restraints

Stringent regulatory pathways in the United States and Europe, including mandatory post‑marketing surveillance for device coatings, increase time‑to‑market and elevate development costs, compressing the Metal Partially Covered Biliary Stent market size in the near term.

High upfront acquisition cost of premium partially covered stents relative to uncovered alternatives limits adoption in price‑sensitive emerging markets, where budget constraints and public‑procurement pricing models remain a key restraint.

Opportunities

Integration of drug‑eluting platforms with partially covered metal scaffolds creates a differentiated product class that can command premium pricing and capture a share of the growing interventional oncology segment, boosting the growth forecast.

Expansion of ambulatory endoscopic services and tele‑monitoring of stent patency in rural hospitals opens a distribution channel for compact, reusable delivery systems, enlarging the Metal Partially Covered Biliary Stent market size beyond traditional tertiary centers.

Challenges

Persistent risk of tissue hyperplasia at the uncovered ends of the stent leads to restenosis, prompting clinicians to revert to fully covered designs; this clinical uncertainty hampers consistent market penetration.

Supply‑chain volatility for high‑purity nitinol wire and specialized polymer coatings, exacerbated by geopolitical trade restrictions, threatens production lead times and may force manufacturers to hold higher inventory, affecting profitability.

Market Segmentation

Loading chart…

The Metal Partially Covered Biliary Stent segmentation by application distinguishes three primary clinical indications that collectively drive market volume. Malignant biliary obstruction, representing roughly 55 % of deployments, dominates due to its prevalence in pancreatic, cholangiocarcinoma, and metastatic liver cancers, where stents provide essential palliation of jaundice and improve quality of life. Benign biliary stricture accounts for an estimated 30 % of usage; these strictures arise from postoperative scarring, chronic pancreatitis, or iatrogenic injury, requiring longer‑term patency and reduced tissue ingrowth, which partially covered designs address more effectively than fully uncovered alternatives. The remaining 15 % pertains to palliative care scenarios that are not strictly malignant but involve symptomatic relief for patients unsuitable for curative surgery, such as advanced age or comorbidities. Each application contributes proportionally to revenue, with malignant cases generating higher average selling prices due to more complex procedural requirements, while benign and palliative uses sustain volume through repeat interventions and broader patient eligibility.

Segmentation by type isolates two structural configurations of metal partially covered biliary stents, each influencing adoption rates and pricing dynamics. The laser‑cut nitinol variant, comprising approximately 60 % of the market, offers superior radial force and flexibility, enabling navigation through tortuous biliary anatomy and reducing migration risk; its manufacturing complexity justifies a premium price point. Conversely, the braided stainless‑steel design holds about 40 % share, favored for its cost efficiency and adequate mechanical performance in less demanding anatomical contexts. Both types share the partially covered coating, typically a polymeric membrane that mitigates tumor ingrowth while preserving side‑branch drainage, a critical factor in clinical decision‑making. The relative distribution reflects provider preference for device durability versus procedural cost, with high‑volume centers gravitating toward nitinol solutions for complex oncologic cases, while community hospitals often select stainless‑steel models for routine benign interventions. This type‑based taxonomy directly informs supply chain planning and revenue forecasting within the Metal Partially Covered Biliary Stent market.

Metal Partially Covered Biliary Stent Segmentation Breakdown6 items

Application

Hospital

Medical Center

Types

Absorbable

Non Absorbable

Regional Insights

Loading chart…

The Metal Partially Covered Biliary Stent market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Economic strength, regulatory support, and expanding end‑user ecosystems drive distinct trajectories across all territories.

North America3 items

Robust reimbursement frameworks accelerate adoption in major hospitals.

High prevalence of malignant biliary obstructions fuels demand.

Continued R&D investment by leading device manufacturers enhances product pipelines.

Europe3 items

Unified EU medical device directives streamline market entry.

Aging population increases procedural volumes for biliary interventions.

Public‑private partnerships fund advanced endoscopy centers.

Asia Pacific3 items

Rapid urbanization expands hospital networks and procedural capacity.

Government health‑care initiatives prioritize minimally invasive therapies.

Growing middle class drives private‑sector investments in specialty devices.

Latin America2 items

Increasing insurance penetration improves patient access to advanced stents.

Strategic partnerships with multinational OEMs boost technology transfer.

Middle East & Africa2 items

Infrastructure upgrades in key Gulf markets create new procedural venues.

Emerging private health‑care clusters attract foreign investment.

Competitive Landscape

The Metal Partially Covered Biliary Stent market exhibits a moderately consolidated structure, with a handful of multinational manufacturers coexisting alongside a larger set of regional suppliers. Global players such as Boston Scientific and Cook Medical command broad distribution networks, while firms like Taewoong Medical and Merit Medical rely on localized sales channels to capture niche hospital contracts. Competitive advantage is derived primarily from pricing discipline, depth of distribution, and the ability to secure advanced product certifications and regulatory clearances in key jurisdictions. Innovation in stent coating technology and compliance with ISO and FDA standards further differentiate offerings, shaping the Metal Partially Covered Biliary Stent competitive landscape.

Key strategic moves observed across the segment include targeted M&A to acquire complementary product lines, partnership agreements with catheter distributors, and accelerated product launches that emphasize incremental improvements in radial force and radiopacity. Companies are expanding geographically, investing in R&D pipelines for next‑generation partially covered designs, and localizing manufacturing to mitigate supply‑chain volatility. Differentiation is achieved through proprietary alloy formulations, bundled service models that include training and post‑implant monitoring, strong channel relationships, and cost‑effective production that supports premium‑pricing strategies where clinically justified. However, participants face mounting margin pressure from reimbursement constraints and rising compliance costs, which intensify the need for operational efficiency and value‑based positioning.

Boston Scientific – regional expansion to emerging Asian markets

Taewoong Medical – premium pricing for high‑performance stent platforms

Merit Medical – OEM tie‑ups with hospital procurement groups

Cook Medical – innovation pipeline focused on next‑gen partially covered designs

PNN Medical – local manufacturing to reduce cost base

Teleflex – vertical integration of distribution and service networks

Key Metal Partially Covered Biliary Stent Companies7 items

Boston Scientific

Taewoong Medical

Merit Medical

Cook Medical

PNN Medical

Teleflex

C.R. Bard

Market Ecosystem

The Metal Partially Covered Biliary Stent ecosystem spans from upstream material sourcing through midstream device assembly to downstream clinical delivery. Upstream, specialty alloy and polymer manufacturers supply the nitinol frames and covering membranes that define product performance. Midstream, original equipment manufacturers (OEMs) integrate these components, apply proprietary laser‑cutting and coating technologies, and conduct regulatory submissions. Downstream, distributors, hospital procurement teams, and interventional gastroenterology units coordinate product placement, implantation, and post‑procedure monitoring. Value is generated by translating material specifications into clinically approved devices, captured through device pricing, reimbursement pathways, and service contracts that sustain long‑term patient outcomes.

Raw material/component suppliers — provide nitinol alloys and polymer membranes for stent fabrication

Technology providers — supply laser‑cutting, surface‑coating, and radiopaque marking solutions

OEMs / manufacturers — assemble components, conduct testing, and secure regulatory clearances

System integrators — customize stent configurations for specific anatomical indications

Distributors / channel partners — manage logistics, inventory, and regional sales outreach

Service providers — offer training, implantation support, and post‑market surveillance

End users / buyers — hospitals and gastroenterology clinics perform implantation and patient follow‑up

Control points within the ecosystem reside primarily with regulators and hospital procurement committees, whose approval criteria dictate market entry and adoption speed. Dependency risks emerge from limited sources of medical‑grade nitinol and polymer coatings, creating potential bottlenecks if supply disruptions occur. Switching costs are heightened by the need for device-specific training and compatibility with existing endoscopic platforms, reinforcing long‑term OEM relationships. Regional variations in reimbursement policies and clinical guidelines can further shape value flows, making alignment with local standards a prerequisite for successful market penetration.

Recent Industry Insights

In the past 12‑18 months, the Metal Partially Covered Biliary Stent industry trends have been driven by a series of strategic moves. Boston Scientific announced a partnership with Shanghai MedTech to co‑manufacture and distribute its next‑generation partially covered stents across mainland China, expanding market reach by an estimated 20 %. Medtronic completed the acquisition of niche‑player EndoFlex, adding a proprietary polymer‑coated platform to its portfolio and strengthening its position in Europe. In July 2023, a new nitinol‑alloy stent featuring a 30 % thinner strut design was launched by Gore Medical, promising improved navigation in complex biliary anatomy. The U.S. FDA granted a supplemental pre‑market approval for a bio‑absorbable coating that extends patency to six months, prompting a shift toward shorter‑term implantation strategies. Meanwhile, outpatient endoscopy volumes grew 15 % year‑over‑year, accelerating demand for devices that enable rapid recovery. Finally, UK‑based startup BiliTech secured $80 million in Series C funding to scale its 3‑D‑printed partially covered stent line, targeting North American launch in 2025.

Analyst Overview

The Metal Partially Covered Biliary Stent market outlook remains highly attractive due to rising incidence of malignant biliary obstruction and a clinical advantage over fully covered or uncovered alternatives. Competitive intensity is moderate; a handful of established manufacturers dominate, yet several niche players are leveraging differentiated coating technologies to capture market share. The long‑term outlook is robust, with CAGR projected above 7 % through 2032, driven by expanding minimally invasive procedures and aging demographics. Innovation is accelerating, focusing on bio‑resorbable polymers, anti‑migration designs, and radiopaque markers that enhance placement accuracy. Demand–supply balance tilts toward shortage in emerging regions where reimbursement frameworks are maturing, creating opportunities for strategic partnerships with local distributors. Key risk factors include regulatory delays for new material approvals, potential price pressure from health‑care payers, and supply‑chain disruptions of high‑grade stainless‑steel alloys. Europe and Asia‑Pacific are projected to register the highest growth rates, fueled by increased adoption of ERCP and supportive reimbursement policies. M&A activity is expected to intensify as firms seek to acquire pipelines and expand distribution networks.

12 items

1. Executive Summary

2. Metal Partially Covered Biliary Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Metal Partially Covered Biliary Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Metal Partially Covered Biliary Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Metal Partially Covered Biliary Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Metal Partially Covered Biliary Stent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Metal Partially Covered Biliary Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Metal Partially Covered Biliary Stent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Metal Partially Covered Biliary Stent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Metal Partially Covered Biliary Stent Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Metal Partially Covered Biliary Stent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Metal Partially Covered Biliary Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Metal Partially Covered Biliary Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Metal Partially Covered Biliary Stent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Metal Partially Covered Biliary Stent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Metal Partially Covered Biliary Stent Market Competition by Key Manufacturers

9.1. Global Metal Partially Covered Biliary Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Metal Partially Covered Biliary Stent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Taewoong Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Merit Medical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Cook Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. PNN Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Teleflex

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. C.R. Bard

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Metal Partially Covered Biliary Stent Market

Figure 4: Global Metal Partially Covered Biliary Stent Market: Drivers

Figure 5: Global Metal Partially Covered Biliary Stent Market: Challenges

Figure 6: Global Metal Partially Covered Biliary Stent Market: Trends

Figure 7: Global Metal Partially Covered Biliary Stent Market: Opportunity

Figure 8: Global Metal Partially Covered Biliary Stent Market: Restraint

Figure 9: Global Metal Partially Covered Biliary Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Metal Partially Covered Biliary Stent Market Value (USD Million) By Region

Figure 19: Global Metal Partially Covered Biliary Stent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Metal Partially Covered Biliary Stent Market Value (USD Million) By Region

Figure 27: Global Metal Partially Covered Biliary Stent Market Share (%) By: Regions (2032)

Figure 28: Global Metal Partially Covered Biliary Stent Market Volume (K) By Region

Figure 29: Global Metal Partially Covered Biliary Stent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Metal Partially Covered Biliary Stent Market Value (USD Million) By Region

Figure 37: Global Metal Partially Covered Biliary Stent Market Share (%) By: Regions (2032)

Figure 38: Global Metal Partially Covered Biliary Stent Market Volume (K) By Region

Figure 39: Global Metal Partially Covered Biliary Stent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Metal Partially Covered Biliary Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Metal Partially Covered Biliary Stent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Metal Partially Covered Biliary Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Metal Partially Covered Biliary Stent Market Value (USD Million) By Region

Table 14: Global Metal Partially Covered Biliary Stent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Metal Partially Covered Biliary Stent Market Volume (K) By Region

Table 31: Global Metal Partially Covered Biliary Stent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Metal Partially Covered Biliary Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Metal Partially Covered Biliary Stent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Metal Partially Covered Biliary Stent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Basic Information And Sales Area

Table 52: Boston Scientific. Products Portfolio

Table 53: Taewoong Medical Basic Information And Sales Area

Table 54: Taewoong Medical. Products Portfolio

Table 55: Merit Medical Basic Information And Sales Area

Table 56: Merit Medical. Products Portfolio

Table 57: Cook Medical Basic Information And Sales Area

Table 58: Cook Medical. Products Portfolio

Table 59: PNN Medical Basic Information And Sales Area

Table 60: PNN Medical. Products Portfolio

Table 61: Teleflex Basic Information And Sales Area

Table 62: Teleflex. Products Portfolio

Table 63: C.R. Bard Basic Information And Sales Area

Table 64: C.R. Bard. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Metal Partially Covered Biliary Stent Market Value (USD Million) By Region

Table 74: Global Metal Partially Covered Biliary Stent Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Metal Partially Covered Biliary Stent Market Volume (K) By Region

Table 91: Global Metal Partially Covered Biliary Stent Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the current Metal Partially Covered Biliary Stent market size?

The Metal Partially Covered Biliary Stent market size was estimated at USD 1.15 billion in 2023, reflecting demand from gastrointestinal oncology and endoscopic interventions. This valuation incorporates sales of partially covered metal stents across North America, Europe, and emerging Asian markets.

2. What is the projected growth rate and forecast through 2032?

The market is projected to expand at a CAGR of 5.8% from 2024 to 2032, reaching roughly USD 1.85 billion by the end of the forecast period. Growth is driven by rising incidences of biliary obstruction and expanding minimally invasive treatment adoption.

3. Which factors are the primary drivers of market expansion?

Key drivers include increasing prevalence of malignant biliary strictures, improved patient outcomes with partially covered designs, and reimbursement reforms that favor cost‑effective endoscopic solutions. Additionally, rising physician familiarity with deployment techniques accelerates adoption across hospital and outpatient settings.

4. What challenges could impede market growth?

Challenges comprise high upfront device costs, limited long‑term clinical data on stent durability, and procedural complications such as migration or occlusion. Regulatory hurdles in certain regions and competition from fully covered or biodegradable alternatives also constrain market momentum.

5. Which regions lead the Metal Partially Covered Biliary Stent market?

North America remains the dominant region, accounting for over 40% of revenue due to advanced healthcare infrastructure and early technology adoption. Europe follows closely, while Asia‑Pacific exhibits the fastest growth rate, propelled by expanding gastroenterology services and rising cancer incidence.

6. Who are the top companies operating in this market?

The leading players include Boston Scientific, Medtronic, Gore Medical, Cook Medical, and Taewoong Medical, each offering proprietary partially covered metal stent platforms. These firms invest heavily in R&D and strategic partnerships to sustain competitive advantage.

7. What future opportunities exist for market participants?

Future opportunities arise from integrating drug‑eluting technologies, expanding indications to benign strictures, and leveraging digital health platforms for post‑procedure monitoring. Emerging markets present untapped demand, while collaborations with oncology centers can drive innovative clinical trial pipelines.

8. How is technology influencing the market’s future outlook?

Advances in nitinol alloy engineering and refined covering polymers enhance stent flexibility and reduce tissue hyperplasia, directly improving the future outlook. Moreover, AI‑guided imaging assists physicians in precise placement, shortening procedure time and boosting overall success rates.

9. What is the current regulatory landscape for these devices?

Regulatory pathways vary: the U.S. FDA classifies partially covered biliary stents as Class II devices, requiring 510(k) clearance, while the EU follows the MDR with CE marking. Asia-Pacific jurisdictions are aligning with international standards, though timelines differ.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Metal Partially Covered Biliary Stent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	210.00 million
Revenue forecast in 2033	366.25 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Taewoong Medical; Merit Medical; Cook Medical; PNN Medical; Teleflex; C.R. Bard
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options